HRL Investor News: If You Have Suffered Losses in Hormel Foods Corporation (NYSE: HRL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 24, 2025 NEW YORK, Nov. 23, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims […]

(NASDAQ:FFAI), The FX Super One and FF 91 2.0 will participate in the LA Auto Show, where our ride-along experiences begin. The Company welcomes everyone to give them a try and place preorders. LOS ANGELES, Nov. 23, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week GlobeNewswire November 24, 2025 The FX Super One and FF 91 2.0 will participate

NEW YORK, NY / ACCESS Newswire / November 23, 2025 / If you suffered a loss on your Freeport-McMoRan Inc. (NYSE:FCX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/freeport-mcmoran-inc-lawsuit-submission-form?prid=178811&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 23, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=178809&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

New York, New York–(Newsfile Corp. – November 23, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Freeport-McMoRan Inc. (NYSE: FCX) between February 15, 2022 and September 24, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline in the securities

Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discoveryand development of novel antibody therapeutics for immunology and oncology, today announced an update and advancement of its global strategic collaboration with AstraZeneca, originally established in March 2025. The collaboration aims to discover and develop next-generation biotherapeutics, including antibody-drug conjugates

New York, New York–(Newsfile Corp. – November 23, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If

Innovent Biologics (Stock Code:01801.HK), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases,announced that it has been successfully added as a constituent stock of the Hang Seng Index (HSI) following the release of the Q3 2025 Hang Seng Index

— WORLD HYDROGEN EXPO 2025 will take place from Wednesday, December 4 to Sunday, December 7 atKINTEX. — The event will showcase a full program, including H2 MEET, the world's largest hydrogen exhibition, and theWHE 2025 Conference featuring global industry leaders. — The scale and stature of the event will be given greater international weight